- Home
- Products
- Customized FluoroAb™
- SAIL
- Anti-SAIL MAb (Clone 1)-iFluor® 450 Succinimidyl Ester
Anti-SAIL MAb (Clone 1)-iFluor® 450 Succinimidyl Ester (CAT#: WJY0-LS6673)
This product is comprised of an Anti-SAIL Antibody (Clone 1) labeled with iFluor® 450 Succinimidyl Ester. iFluor® 450 Succinimidyl Ester is a Green-fluorescent dye and it's excitation/emission is 403/427 nm.
- TARGET
- ANTIBODY
- DYE
- Name
- SAIL
- Overview
- Anti-SAIL Antibody (Clone 1)
- Species Reactivity
- Human
- Name
- iFluor® 450 Succinimidyl Ester
- Color
- Green
- Excitation⁄Emission (nm)
- 451/502
- Detection method
- Fluorescent
Published Data
+ Submit Publications
Scientific Resources
Customer Reviews and FAQs
There are currently no Customer reviews or questions for WJY0-LS6673. Click the button above to contact us or submit your feedback about this product.
Quick Links
Other Products
Same Target
| CAT# | Product Name | Linker | Payload |
| ADC-W-553 | Anti-SAIL-Mc-MMAF ADC-1 | Mc (maleimidocaproyl) | MMAF (Monomethyl auristatin F) |
| ADC-W-552 | Anti-SAIL-Mc-MMAF ADC-2 | Mc (maleimidocaproyl) | MMAF (Monomethyl auristatin F) |
For Research Use Only. NOT FOR CLINICAL USE.
Related Products
- Anti-MSTN MAb (Clone 4)-iFluor® 350 Succinimidyl Ester (CAT#: WJY0-LS667)
- Anti-CEACAM5 MAb (Clone 9)-iFluor® 450 Succinimidyl Ester (CAT#: WJY0-LS7190)
- Anti-CD70 MAb (Clone 8)-iFluor® 514 Succinimidyl Ester (CAT#: WJY0-LS11238)
- Anti-IFNA1 MAb (Clone 4)-iFluor® 546 Succinimidyl Ester (CAT#: WJY0-LS15118)
- Anti-C5 MAb (Clone 2)-iFluor® 532 Succinimidyl Ester (CAT#: WJY0-LS12887)
- Clenoliximab-Coumarin (CAT#: ADC-FL-697)
- Anti-CXCR4 MAb (Clone 4)-iFluor® 460 Succinimidyl Ester (CAT#: WJY0-LS8661)
- Anti-MUC1 MAb (Clone 16)-iFluor® 514 Succinimidyl Ester (CAT#: WJY0-LS11645)
- Anti-EGFR MAb (Clone 8)-iFluor® 514 Succinimidyl Ester (CAT#: WJY0-LS11008)
- Anti-CD33 MAb (Clone 3)-iFluor® 546 Succinimidyl Ester (CAT#: WJY0-LS14140)
Online Inquiry
Welcome! For price inquiries, please feel free to contact us through the form on the left side. We will get back to you as soon as possible.
